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1. Introduction 
Abdominal Aortic Aneurysm (AAA) is defined as a localized and permanent dilatation of 
the abdominal aorta, beyond 50% of the normal aorta diameter (Schermerhorn, 2009). The 
prevalence of AAA ranges from 1.3% to 8.9% in men and 1% to 2.2% in women (Sakalihasan 
et al., 2005; Singh et al., 2001). Incidence of AAA is on the rise in parallel with a globally 
ageing population, higher clinical suspicion and improved accuracy of imaging methods 
(Best et al., 2003; Prisant & Mondy, 2004). AAA is an important problem for public health, 
since AAA rupture is the tenth leading cause of death in American white men 65 to 74 years 
of age (Upchurch & Schaub, 2006). Most AAA remain asymptomatic until rupture occurs. 
Half of the patients with a ruptured AAA reach the hospital alive, with an additional 
operative mortality of 30-60%. On the contrary, an elective AAA repair, recommended in 
most patients with an abdominal aortic diameter exceeding 50-55 mm or rapid growth (> 1 
cm/y), is associated with a mortality risk of 2% to 6% (Kurvers at al., 2003; Sakalihasan et 
al., 2005). Health organizations recently recommended one-time screening for AAA by 
ultrasonography for men aged between 65 and 75 years with a smoking history, thereby 
reducing AAA related mortality rates by 50% (Cosford & Leng, 2007; Ehlers et al., 2008; 
Ferket et al., 2011; Moxon et al., 2010; Takagi et al., 2010). However, they advised against 
screening in men below 65 and over 75 years, and in women, since the number of AAA-
related deaths that can be prevented by screening these populations is too small. AAA and 
atherosclerosis share several risk factors, such as male sex, age, smoking and arterial 
hypertension (Forsdahl et al., 2009). In population – based studies, AAA is independently 
associated with pre – existing coronary arterial disease (CAD) (Golledge et al., 2006; Kent et 
al., 2010). The high prevalence of CAD among patients with AAA is well known, with an 
impact on short term survival after AAA repair (Falk et al., 1997). Indeed, coronary 
investigation is often required prior to aortic surgery, finding a concomitant CAD 
prevalence of 31% to 90% (Kioka et al., 2002; Sukhija et al., 2004; Van Kuijk et al., 2009). In 
contrast, the opposite relationship, namely the prevalence of AAA among patients with 
CAD, has been explored only in some recent cohorts or in subgroups of patients. The 
possibility that AAA could be more prevalent in this population, as compared with the 
general population, has been suggested by these previous studies, with limited, incomplete 
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and often conflicting results. Accordingly, no specific recommendation is available on AAA 
screening in patients with advanced atherosclerosis. To our knowledge, we present the first 
systematic review, based on a thorough literature survey, which delineates the prevalence 
and predictive risk factors of AAA among CAD patients. We thus aim at identifying CAD 
patients at high risk for AAA development and discussing the usefulness of AAA screening 
in such subpopulations. 
2. Methods 
A systematic English-language literature search has been performed using the 
MEDLINE/Pubmed, Cochrane and Embase databases to identify all studies on the 
prevalence and risk factors of AAA among CAD patients, published from January 1985 to 
January 2011. The key words searched for were AAA and CAD. The title and relevant 
abstracts have been screened for studies which statistically analyzed prevalence data of 
AAA in CAD patients. In addition, the references of eligible papers were screened for 
further relevant studies. Two authors independently reviewed and extracted data from each 
article using a specific data extraction form: publication year, characteristics of study 
population including CAD severity, AAA definition, size, prevalence, associated risk factors 
and circulating biomarkers. Discrepancies were resolved by consensus.  
3. Characteristics of abdominal aortic aneurysm in coronary artery disease 
patients 
Seventeen studies (8308 patients) published between 1991 and 2010 were eligible, meeting 
the predetermined inclusion criteria (table 1). Study population ranged from 72 to 2819 
patients. For some studies, only the subgroup of CAD patients received our attention (Abela 
et al., 2009; Alcorn et al., 1996; Benzaquen et al., 2001; Bonamigo & Siqueira, 2003; Goessens 
et al., 2006; Jaussi et al., 1999; Nemati et al., 2009).  
In these studies, the prevalence or incidence of AAA among CAD patients oscillated 
between 0.48% and 18.2%, with 8 studies above 9% (upper limit of AAA prevalence in 
population – based studies). The prevalence of AAA eligible for surgical repair varied from 
0% to 5.2 % of the study population, and from 0% to 36.7% of the AAA population (table 2). 
AAA diameter in these studies ranged between 25 and 87 mm. Five studies included a 
control population, age and sex matched in most cases, and without angiographic CAD 
(Bergersen et al., 1998; Bonamigo & Siqueira, 2003; Madaric et al., 2005; Nemati et al., 2009; 
Wang et al., 2008). AAA prevalence in these control groups were always significantly below 
the prevalence in the CAD group, ranging from 0 to 3.3%.  
4. High heterogeneity of studies 
The wide variations in AAA prevalence among the precited 17 studies could be explained 
by differences in severity of CAD, AAA definition, age and sex distribution, geographical 
localisation, prevalence of associated risk factors and pre-existing atherosclerosis-related 
morbidity.  
Inclusion criteria clearly stated a wide range of CAD severity: current coronary 
angiographic data with various thresholds of significant coronary narrowing; data on 
previous coronary events; data on current or previous coronary revascularisation 
procedures whether endovascular or surgical. Nine out of the 17 studies included patients 
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Reference Study Design, Country 
n 
patients 
( male) 
AAA 
(%) 
Nevelsteen et al., 
1991 
Post CABG, Belgium 100 (80) 11* 
Alcorn et al., 
1996 
Aged > 65 years, MI, angina, CABG, significant stenosis 
on coronary angiography, USA 
1244 13.8 
Bergersen et al., 
1998 
Elective CABG patients, USA 
192 
(65.6) 
18.2 
(13.0*) 
Jaussi et al., 1999
Patients referred for Transthoracic Echocardiography 
with ischemic heart disease, Switzerland 
72 15.3* 
Benzaquen et al., 
2001 
Significant angiographic coronary stenosis, Canada 99 (75) 8.1* 
Bonamigo & 
Siqueira, 2003 
Male aged > 54 years, severe ischemic disease (stenosis > 
70%) and previous coronary surgery, or important lesions 
on cardiac catheterism, Brazil 
501 6.8* 
Monney et al., 
2004 
Male aged > 60, Post CABG, Switzerland 395 10.1* 
Calderwood & 
Welch, 2004 
CABG patients, United Kingdom 118 15.3 
Madaric et al., 
2005 
Age > 60 years, coronary narrowing ≥ 50%, Slovak 
Republic 
109 (90) 
14.7 
(8.3*) 
Goessens et al., 
2006 
"SMART Study", MI, unstable angina or history of CAD 
or CABG/PCI, The Netherlands 
1034 (83) 
3.7 
(2.2*) 
Wang et al., 2008 Age > 60 years, coronary narrowing ≥ 50%, China 209 
(72.7) 
0.48* 
Abela et al., 2009 Significant coronary stenotic lesions, United Kingdom 87 (77) 13.8 
Shirani et al., 
2009 
Elective candidates for CABG, Iran 
2819 
(69.6) 
2.09 
Nemati et al., 
2009 
CAD (more than 50% constriction), Iran 184 4.3 
Dupont et al., 
2010 
Post CABG, France 217 (87) 6.9 
Long et al., 2010
Acute coronary syndrome with coronary stenosis ≥ 50%, 
France 
304 (77) 6.6* 
Poon et al., 2010 Elective patients for CABG, China 
624 
(79.9) 
1.8 
Table 1. Summary of studies reporting prevalence or incidence (*) rates of abdominal aortic 
aneurysm (AAA) among coronary artery disease (CAD) patients. CABG: coronary artery 
bypass graft, MI: myocardial infarction, PCI: percutaneous coronary intervention 
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Reference 
AAA diameter 
mean (SD), [range]
(mm) 
AAA > 50 mm % 
/ study population
AAA > 50 mm % 
/ AAA patients 
Nevelsteen et al., 1991 [30-65] 4 36.7 
Bergersen et al., 1998 43.6 (13.1), [25-70] 5.2 28.6 
Benzaquen et al., 2001 38 (14), [27-65]  1 12,5 
Monney et al., 2004 38.9 (13) 1.01 10 
Calderwood & Welch, 2004  4.2* 27.7* 
Madaric et al., 2005  4.6 31.2 
Goessens et al., 2006  0.09* 4.34* 
Abela et al., 2009 42 (19.6), [30-87]  1.1 11.1 
Shirani et al., 2009 30.70 (7.01), [25-61.7] 0.07* 3.4* 
Dupont et al., 2010 35.3 (9.1), [26-53]  0.9 13.3 
Long et al., 2010 33 (3.7), [30-45]  0 0 
Poon et al., 2010 [31.1-59.1] 0.3 18.2 
Table 2. Characteristics of abdominal aortic aneurysm (AAA) in coronary artery disease 
patients (*: >55 mm). 
who were candidates for CABG or in the post CABG period (table 1). AAA was diagnosed 
by abdominal ultrasound, by measurement of either transverse or antero-posterior, or both 
infrarenal aortic diameters. AAA is conventionally defined when infrarenal aortic diameter 
is ≥ 30 mm (Moll et al., 2011; Wanhainen et al., 2001; Wanhainen et al., 2008). In the present 
review, fifteen studies used this definition. However, some studies diagnosed AAA when 
infrarenal aortic diameter was > 26 mm (Calderwood & Welch, 2004) or ≥ 25 mm (Shirani et 
al., 2009), while others used additional criteria: infrarenal to suprarenal ratio > 1.2 (Alcorn et 
al., 1996) or > 1.5 (Dupont et al., 2010), infrarenal exceeding suprarenal aortic diameter by at 
least 5 mm (Bonamigo & Siqueira, 2003), to compensate for individual variation in the 
diameter of the adjacent aorta. While two studies exclusively included male patients 
(Bonamigo & Siqueira, 2004; Monney et al., 2004), the other studies recruited a female 
patient proportion varying from 10 to 34.4%. Because age is an important risk factor for both 
CAD and AAA in population – based studies, five studies restricted their study population 
to patients above 60 years. While most recruited patients had a mean age between 60 and 70 
years, some studies exhibited a wide age range (from 34 to 88 years; from 29 to 83 years; 
respectively) (Long et al., 2010; Poon et al., 2010). In contrast to a majority of CAD patients 
of Caucasian origin in these studies, we found two studies on prevalence of AAA in CAD 
patients of Chinese origin (Wang et al., 2008; Poon et al., 2010) and two on Iranian patients 
(Shirani et al., 2009; Nemati et al., 2009). These 4 studies reported the lowest AAA 
prevalence. It clearly appears that certain ethnic groups experience a disproportionately 
smaller burden of AAA (Salem et al., 2009). Emphasis should be done upon the fact that the 
size of abdominal aorta in these populations was quite smaller than in Caucasian 
population. Wang et al. and Poon et al. consistently found a mean maximal infrarenal aortic 
diameter inferior to studies of Caucasian population (Allison et al., 2008; Poon et al., 2010; 
Wang et al., 2008). Despite such heterogeneity between these observational cross – sectional 
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studies, one can fairly say that AAA prevalence among CAD patients exceeds that observed 
in population –based studies. It is also of interest that the prevalence of AAA in CAD 
patients was comparable to that reported in AAA screening studies of patients with 
peripheral vascular disease (7% -17%) and cerebrovascular disease (8.4% -20.2%) (Bentgsson 
et al., 1996; Kurvers et al., 2003; Palazzuoli et al., 2008; Simons et al., 1999). 
5. Abdominal aortic aneurysm risk factors in coronary artery disease patients 
We shall now stress on the association between AAA prevalence in CAD patients and the 
various coronary atherosclerosis risk factors or indicators which may be useful to identify 
patients at increased risk in a screening context. Of importance, some risk factors were 
examined in some studies but not in others (table 3). 
5.1 Gender 
Most studies including both male and female patients showed a trend towards a higher 
male prevalence among AAA cases (table 3) or detected AAA in male patients exclusively, 
in accordance with results of population – based studies (Dupont et al., 2010; Nemati et al., 
2009; Nevelsteen et al., 1991; Wang et al., 2008). Only one study showed a statistically 
significant association between male sex and AAA prevalence (table 3) (Shirani et al., 2009). 
 
 
Reference Male sex Age Smoking 
Diabetes 
mellitus 
Arterial 
hypertension 
Bergersen et 
al., 1998 
1.78 (0.67-4.7)
5,7 (1,7-18,8)*, 
§ 
7 (2,5-19,1)*,§   
Bonamigo & 
Siqueira, 2003 
 
1,09 (1,034-
1,152)*, § 
0,96 (0,47-1,95) 1,29 (0,58-2,86) 1,53 (0,79-2,99) 
Monney et al., 
2004 
 *, § 
2,07 (1,05-4,1)*, 
§ 
0,4 (0,14-1,16)
2,67 (1,2-5,96)*, 
§ 
Madaric et al., 
2005 
1,11 (0,28-4,35) 1,05 (0,95-1,17)
4,85 (1,55-
15,25)*, § 
0,11 (0,01-
0,83)* 
2,66 (0,33-
21,75) 
Shirani et al., 
2009 
3,85 (1,65-
8,99)* 
age > 65: 1,79* 1,63* 2,32* 1,85* 
Nemati at al., 
2009 
 *    
Dupont et al., 
2010 
NS 1.34 (0.47-3.83) infinity* 1,7 (0,58-4,99) 0,76 (0,26-2,22) 
Long et al., 
2010 
2,83 (0,64-
12,51) 
age > 60: 2,74 
(1,07-7)*,§ 
2,01 (0,65-6,18) 0,54 (0,18-1,66) 1,07 (0,42-2,7) 
Poon et al., 
2010 
2.17 (0.49-9.52) 2.68 (0.74-8.96) NS NS NS 
Table 3. Odds ratio (95% confidence interval) obtained for association studies between 
abdominal aortic aneurysm presence and some atherosclerosis risk factors, among coronary 
artery disease patients. *: p< 0.05 by univariate analysis, §: p< 0.05 by multivariate analysis, 
NS: non significant 
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Poon et al. exclusively detected AAA in male CAD patients when using the common AAA 
definition “infrarenal aortic diameter ≥ 30 mm” (Poon et al., 2010). However, when using an 
alternate definition “maximum infrarenal diameter 1.5 times the group mean infrarenal 
aortic diameter categorized by gender”, AAA prevalence was greater with 2 out of 19 in 
female patients (infrarenal aortic diameter of 24.1 mm and 25.1 mm). This goes along with 
the suggestion by Grootenboer et al. by which the definition of 30 mm in population based 
studies for the average women is probably inappropriate and leads to an underestimation of 
AAA prevalence (Grootenboer et al., 2009). In these studies on AAA prevalence in CAD 
patients, one also notes that infrarenal aortic diameter mean (standard deviation), when 
available, was significantly lower in female compared to male patients : 15.5 (2.2) mm versus 
18.8 (5.6) mm, p<0.0001 in Dupont et al. (Dupont et al., 2010), 16.8 (3.2) mm versus 20.2 (3.3) 
mm, p=0.004 in Nevelsteen et al. (Nevelsteen et al., 1991).  
5.2 Age 
Nine out of 17 studies reported a statistical evaluation of the association between age and 
AAA (table 3). Only 2 did not find an association (Dupont et al., 2010; Poon et al., 2010). Age 
was associated with AAA by multivariate analysis after adjustment for other known risk 
factors in 4 studies (table 3). In Nemati et al., ROC curve analysis showed that age of 
patients with CAD (67 years) predicted the presence of AAA with a sensitivity and 
specificity of 75% and 80%, respectively (Nemati et al., 2009). Although most guidelines 
contain recommendations that favour one time AAA screening for male patients 65 years or 
older in the general population, one can note that 6 out of the 17 studies gave data about 
AAA detection in men younger than 65 years (table 4).  
 
Reference AAA age 
Dupont et al., 2010 67.1 (9.8), [54-85] 
Goessens et al., 2006 68.8 (11,5), [45-79] 
Long et al., 2010 69 (11), [51-86] 
Calderwood et al., 2004 64.8, [60-72] 
Benzaquen et al., 2001 67.2 (5.4), [58-76] 
Abela et al., 2009 68.8 (11,5), [45-79] 
Nemati et al., 2009 68.2 (7,09) 
Table 4. Age distribution of abdominal aortic aneurysm (AAA) patients among coronary 
artery disease patients (mean (SD), [min-max]) 
Only the AAA that are vulnerable to rupture contribute to the benefit of screening at an 
earlier age (Ferket et al., 2011). As an example, in Dupont et al., 7 out of 15 AAA were 
detected in men aged 50 to 65 years with one of them exceeding 50 mm requiring surgical 
correction (Dupont et al., 2010). In Long et al., 7 out of 20 AAA were detected in CAD 
patients aged 50 to 60 years (Long et al., 2010). 
5.3 Smoking 
Over 90% of all AAA patients have a history of smoking, and nearly half are active smokers 
at the time of diagnosis (Powell et al., 1996). In population – based studies, smoking may be 
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more strongly associated with AAA than with CAD (3 fold) or with cerebrovascular disease 
(5 fold) (Lederle et al., 2003). It also was strongly associated with AAA progression and 
rupture (Badger et al., 2009) and the strength of its association with AAA persisted 
independently of the extent of atherosclerotic disease (coronary, peripheral artery disease) 
(Lee et al., 1997). Five out of the 17 studies on AAA prevalence in CAD patients showed 
smoking to be significantly associated with AAA by univariate analysis, 3 of them 
confirming this association by multivariate analysis (table 3). In Shirani et al., even more 
important was the duration of smoking as 8.6% of CAD patients with a history of smoking ≥ 
40 years had AAA compared to an AAA prevalence of 2.6% in their whole CAD population 
(Odd Ratio (OR): 3.49, p=0.0001) (Shirani et al., 2009). Similar results were found in 
population based studies (Singh et al., 2001). The effect of smoking cessation has been 
investigated as well, and showed a slow decrease in risk for AAA of 4% per year (95% 
confidence interval 2 to 6) (Wilmink et al., 1999). However, when adjusting for smoking 
duration, the risk of AAA even 20 years after cessation of smoking was not statistically 
different from the risk of current smokers (Singh et al., 2001). Nontheless, the recent AAA 
clinical practice guidelines of the European Society for Vascular Surgery recommend 
smoking cessation to reduce the risk of AAA growth (Moll et al., 2011). This relative slow 
decline in risk, after cessation of smoking, differs strongly between AAA and CAD. It would 
be interesting to evaluate the impact of smoking cessation on AAA prevalence and 
progression among CAD patients. 
5.4 Diabetes mellitus  
Among the 17 studies on AAA prevalence in CAD patients, only 7 did focus on the 
association between Diabetes Mellitus (DM) and AAA prevalence (table 3). Five out of these 
7 studies reported no association, while one showed an association by univariate analysis 
which was no more significant by multivariate analysis (Madaric et al. 2005). Shirani et al. 
reported a significantly higher frequency of AAA in diabetic patients compared with non 
diabetic ones (3.2% versus 1.4%, p=0.033) (Shirani et al., 2009). Of importance, Guijarro et al. 
studied 159 patients with CAD and found that microalbuminuria, but not DM, was a potent 
and independent predictor of AAA (OR: 7.56, 95% Confidence interval: 1.8-31.9) (Guijarro et 
al., 2006). DM, a strong coronary atherosclerosis risk factor, may therefore lack an 
association with AAA prevalence in CAD patients.  
5.5 Arterial hypertension 
Seven out of the 17 papers on AAA prevalence in CAD patients evaluated the association 
between AAA and arterial hypertension. Only Shirani et al. and Monney et al. confirmed a 
significant association (table 3) (Monney et al., 2004; Shirani et al., 2009). Arterial 
hypertension seems to be more positively associated with coronary heart disease and 
cerebrovascular disease than with aneurysm formation. These findings indicate that a 
history of hypertension should not be held as a significant risk factor for AAA among CAD 
patients.  
5.6 Lipid profile and obesity 
Most CAD patients receive a lipid modifying therapy including statins, fibrates and 
cholestyramine. In such populations, few studies did evaluate the association between 
serum lipoproteins levels or history of dyslipidemia and AAA prevalence (Dupont et al., 
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2010; Monney et al., 2004; Shirani et al., 2009). None found a statistically significant 
association. Moreover, in view of current guidelines on atherosclerosis treatment, one 
cannot construct a study on association between basal lipid profile and AAA prevalence in 
CAD patients without lipid modifying therapy prescription. We can, therefore, not expect to 
withdraw conclusions in such a selective population. 
As far as obesity is concerned, 3 studies reported on the lack of association between AAA 
and BMI and/or body weight in CAD patients (Dupont at al., 2010; Long et al., 2010; 
Monney et al., 2004). A potential association between obesity and AAA or infrarenal aortic 
diameter in CAD patients requires evaluation by further studies. 
To date, in a CAD population, all evaluated potential AAA risk factors are also well – 
known CAD risk factors. Among these, only age and smoking seem to have a specific 
impact on AAA prevalence among CAD patients. Of importance, no known specific 
circulating biomarker of AAA in CAD patients is available. 
6. Atherosclerosis and abdominal aortic aneurysm 
6.1 Pathophysiology 
The pathogenesis of AAA is poorly understood. AAA has traditionally been thought to be 
caused by atherosclerosis. Recently, this atherosclerosis theory has been challenged on the 
basis of epidemiologic, genetic and biochemical information, questioning whether 
atherosclerosis is a “bystander” condition or an active participant in the development and 
progression of AAA disease (Golledge & Norman, 2010; Johnsen et al., 2010; Lee et al., 1997; 
Reed et al., 1992; Trollope & Golledge, 2011). As seen in previously described studies on 
AAA prevalence in CAD patients, not all patients with atherosclerotic disease do present an 
AAA. On the opposite, several studies reported many AAA patients lacking concomitant 
atherosclerotic vascular disease. The link between AAA formation and atherosclerosis is 
also not strong in animal models. Animals developing atherosclerosis by dietary or genetic 
means scarcely develop an AAA. Conversely, animal models of AAA, by intraluminal 
elastase infusion or adventitial application of calcium chloride, do not require the presence 
of atherosclerosis. There are both similarities and differences in the pathogenesis of AAA 
and atherosclerotic lesions whether coronary, carotid or peripheral arterial diseases. Both 
involve inflammation, macrophage infiltration, increased vascular smooth muscle cells 
turnover and thrombus formation. Whereas proliferation of vascular smooth muscle cells 
(VSMCs) is a typical feature of atherosclerosis affecting vascular media and intima, the 
density of these cells is low in media and adventitia of aneurismal wall due to apoptosis. 
Atherosclerosis is also characterized by migrating VSMCs and macrophages, foam cell 
formation, lipid deposition, leading to endothelial dysfunction and increased intima – media 
thickness (Palazzuoli et al., 2008). On the other hand, AAA involves dilation of all layers of 
the aortic wall, destructive remodeling of medial elastin and collagen fibers by matrix 
metalloproteinases released by activated aortic wall macrophages (Wassef et al., 2007). 
These different pathological features of CAD and AAA are further emphasized by the 
results of above mentioned observational studies. Indeed, some of the risk factors for CAD 
did emerge as being independently associated with AAA in severe CAD populations such 
as cigarette smoking and age. However, it is not possible to determine from these studies 
whether these risk factors did so through a pathway of promoting atherosclerosis, in turn 
increasing the risk of AAA, or if they promoted AAA further leading to CAD development. 
A third theory could be that both pathways act to some extent, subsequently stimulating the 
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development of the other. New integrative, hypothesis – driven, carefully designed human 
and animal studies should shed a light on the sequential development of AAA and coronary 
atherosclerosis.  
6.2 Severity of CAD and AAA 
Severity of CAD has been differently described in the aforementioned studies. Long et al. 
described a significant positive association between AAA and previous coronary events 
(previous acute coronary syndromes with proven coronary stenosis of 50% or greater, 
CABG or percutaneous coronary intervention), but not with the number of stenosed 
coronary vessels (Long et al., 2010). Nemati et al. as well as Shirani al. reported no 
association between AAA and number of stenosed coronary vessels or left main coronary 
vessel stenosis (Nemati et al., 2009; Shirani et al., 2009). Monney et al. confirmed these 
results regarding the lack of association between AAA and number of stenosed coronary 
vessels, NYHA classification of Angina Pectoris and number of bypass (Monney et al., 2004). 
Nevertheless, there was a reduced risk among patients with a single coronary vessel 
affection as compared to patients with CAD involving two or three vessels. Likewise, 
Dupont et al. did not detect an association between AAA and history of unstable/ stable 
angina, myocardial infarction, coronary angioplasty, and number of diseased coronary 
vessels (Dupont et al., 2010). Such an association or lack thereof between AAA and CAD 
severity has not been evaluated in population – based studies. It would also be important to 
assess the relationship between extent of coronary stenosis and infrarenal aortic diameter 
and/or risk of AAA rupture.  
6.3 Concomitant vascular disease to abdominal aortic aneurysm and coronary artery 
disease 
Atherosclerosis is a systemic inflammatory vascular disorder involving multiple arterial 
beds, so it makes sense to evaluate AAA prevalence among patients when Peripheral 
Arterial Disease (PAD) and/or Carotid Artery Stenosis (CAS) coexist with CAD. Patients 
with PAD seem to be at particularly high risk for AAA development with an overall 
prevalence greater than 10%, twice that of the general population (Barba et al., 2005; 
Galland, et al., 1991). In Barba et al., patients with tibial disease had a significantly higher 
AAA prevalence than those patients with aortoiliac or femoro-popliteal diseases. A 
systematic review of population based screening studies has shown a positive association of 
PAD with AAA (OR 2.5) (Palazzzuoli et al., 2008). The relationship between AAA and CAS 
is more difficult to apprehend. In patients aged above 65 years with severe CAD awaiting 
CABG, a recent study showed the presence of an AAA to be a significant predictor of  70% 
internal carotid artery stenosis by univariate analysis (Kiernan et al., 2009). Furthermore, a 
higher prevalence of AAA has been established in patients with CAS (Gratama et al., 2010; 
Kang et al., 1999; Karanjia et al., 1994; Kurverts et al., 2003). However, recent case control 
studies did not find any evidence for more carotid atherosclerosis in AAA patients (Cheuk 
et al., 2007; Palazzzuoli et al., 2008). In an attempt to better elucidate this relationship, 
Johnsen et al. reported significantly more carotid atherosclerosis in abdominal aortic 
aneurysm diameter  27 mm and in AAA (Johnsen et al., 2010). 
Among CAD patients, 5 studies appraised an association between AAA and PAD, while the 
association between AAA and CAS was analyzed in only 4 studies (table 5). Regarding 
PAD, Benzaquen et al. and Dupont et al. reported a significant association (Benzaquen et al., 
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2001; Dupont et al., 2010). This was further confirmed by Guijarro et al. in 157 patients with 
CAD (angina, acute coronary syndromes, or myocardial infarction) out of a cohort of 269 
patients with symptomatic atherosclerosis (Guijarro et al., 2006). PAD was a potent and 
independent predictor of AAA (Odd Ratio: 6.0, 95% CI: 1.4-26.6). Of importance, in 
Benzaquen et al., difficulty advancing the catheter into the aorta during coronary 
catheterization was the only independent predictor of AAA presence by multivariate 
analysis (Odd Ratio: 11.1, 95% CI: 4.6-26.6) (Benzaquen et al., 2001). The association of AAA 
with concomitant lower extremity PAD may be due to the strong pathophysiologic 
association of both AAA and PAD with smoking. Both the aorta and lower extremity 
arteries are especially susceptible to injury by exposure to all forms of tobacco and cigarette 
smoking in particular (Baumgartner et al., 2008). As for CAS, its presence was associated 
with an increased risk of AAA in 3 out of 4 studies (table 5). In Shirani et al., AAA frequency 
was 10.8% in patients older than 65 years and CAS >50% (Shirani et al., 2009). In Dupont et 
al., severe CAD male patients aged below 75 years with a smoking history had an AAA 
prevalence of 24% when they also had PAD and/or CAS, versus 4.4% in the absence of 
either condition (p=0.007) (Dupont et al., 2010). 
 
Reference Carotid stenosis 
Peripheral arterial 
disease 
Benzaquen et al., 2001  4.7 (2.1-10.3)* 
Bonamigo & Siqueira, 2003  0,66 (0,21-2,1) 
Monney et al., 2004 0,9 (0,36-2,24) 1,88 (0,78-4,56) 
Madaric et al., 2005 3,11 (1,02-9,46)* 3,07 (0,91-10,38) 
Shirani et al., 2009 4,72*  
Dupont et al., 2010 4,88 (1,37-17,33)* 5,45 (1,77-16,78)* 
Table 5. Odds ratio (95% confidence interval) obtained for association studies between 
abdominal aortic aneurysm presence and carotid artery stenosis or peripheral arterial 
disease, among coronary artery disease patients. *: p< 0.05 by univariate analysis 
7. AAA screening 
AAA appears to meet many of the classic criteria of disease screening (Wilson & Jungner, 
1968). First, AAA is an important health problem disease with life – threatening 
consequences when rupture occurs. Its prevalence in cross sectional studies is on the rise, 
not only because of better case – finding by abdominal ultrasonography, but also due to 
ageing of the population. In carefully designed randomized controlled trials, it has been 
well established that AAA screening in men aged 65 to 74 years is effective and decreases 
the risk of aneurysm rupture by almost 50%. In this group, after a single abdominal 
ultrasonographic evaluation, death from aortic rupture is rare within the subsequent 10 
years (Ashton et al., 2002; Lindholt et al., 2002; Lindholt et al., 2005; Thompson et al., 2009; 
Wilmink et al., 2003). The evidence of clinical effectiveness was reinforced by a subsequent 
Cochrane Review—which estimated a 40% relative risk reduction in aortic rupture (absolute 
risk reduction from 0.27% to 0.16%)—and then by results from MASS after 7 years of follow-
up (Cosford & Leng, 2007; Kim et al., 2007). A second point is that abdominal 
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ultrasonography is an ideal method for AAA screening as it is safe, non – invasive, cheap, 
lasting only few minutes, with a high sensitivity and specificity (Lederle et al., 1988; 
Lindholt et al., 1999). Thirdly, the best therapy is pre-symptomatic elective surgery in 
appropriately selected individuals, with a mortality of 5% for elective surgery, one tenth the 
mortality of emergency interventions (Golledge & Norman, 2009). Accordingly, population-
based screening is currently being implemented in several countries (Scott et al., 2008; 
Wannheinen et al., 2005; Swedish council on technology assessment in health care, 2008). 
Most clinical practice guidelines contain recommendations in favor of one – time AAA 
screening for men 65 – 75 years old with a history of smoking using ultrasonographic scans 
(Ferket et al., 2011). However, this recommendation is poorly followed up in this target 
population, partly due to a lack of patients’ compliance with an acceptance rate around 65% 
(Boll et al., 1998; Collin et al., 1988; Lederle et al., 1997; Lindholt et al., 1997; Simoni et al., 
1995). Moreover, a recent study estimates that about half the patients with AAA were not 
eligible for screening under current guidelines and would have been missed (Kent et al., 
2010). A different approach, with screening of specific high-risk groups has been suggested 
(Derubertis et al., 2007) and is implemented within the Medicare programme in the United 
States (Lederle, 2008). No specific guidelines for AAA screening in CAD patients are 
available. In those articles dealing with AAA prevalence among CAD patients, we found a 
higher AAA prevalence among Caucasian patients (between 3.7 and 18.2%) compared to 
population – based studies, with a high prevalence of AAA above 50 mm, independently of 
CAD severity. Such prevalence seems to be higher, according to our review, when CAD 
patients have a smoking history and symptomatic atherosclerotic affection of other vascular 
beds (CAS and PAD). These data lend support to further urgent controlled randomized 
studies, dealing with AAA ultrasonographic screening in this specific subpopulation, with a 
longer follow up of included subjects. End goals would include cost effectiveness, AAA 
operability, long term survival, sufficiency of one – time screening and quality of life. The 
impact of cardiovascular co – morbidities has been implicated, by predictive scoring 
systems, to influence AAA prevalence in the subgroups of women and middle – aged men 
(50 to 65 years old) (Kent et al., 2010; Wanhainen et al., 2008). The screening of hospitalized 
CAD patients would be easily organized without adding administrative burden and of high 
efficiency, as evidenced by full attendance rates in studies of Monney et al. and Dupont et 
al.; as abdominal ultrasonography was proposed during hospitalization (Monney et al., 
2004; Dupont et al., 2010).  
8. Conclusion 
This review of literature shows, despite the limited number of studies, that CAD patients 
present with a higher AAA prevalence compared to population – based studies. Some 
classic atherosclerosis risk factors (history of smoking, age, associated atherosclerotic 
affection of other vascular beds) maintain an association with AAA in such CAD 
populations. This has a two-fold consequence: first, AAA may not simply be an 
atherosclerotic complication, as suggested by a recent work based on TROMSO study, 
warranting further studies in AAA pathogenesis (Johnsen et al., 2010). Secondly, specific 
CAD subgroups (those showing the above mentioned common risk factors) may be at risk 
for a higher AAA burden, strongly justifying the need for further studies to evaluate the 
impact of AAA screening in such patients subgroups. 
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